Backed by market attractiveness analysis, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, wider supply chain intelligence, emerging startup coverage, and detailed product-level insights, The Business Research Company’s 2026 market reports are designed to offer research that is more actionable and strategically valuable than ever.
Implantable Insulin Pump Market Forecast: Value Set To Climb From $4.26 Billion To $6.09 Billion
The implantable insulin pump market size has shown substantial growth in recent years. It is projected to increase from $3.88 billion in 2025 to $4.26 billion in 2026, with a compound annual growth rate (CAGR) of 9.7%. The expansion observed in the historic period stems from the rising prevalence of type 1 diabetes, the drawbacks of multiple daily insulin injections, the initial stages of implantable pump technology development, increasing recognition of intensive insulin therapy, and existing hospital-based diabetes management practices.
The implantable insulin pump market is anticipated to experience substantial expansion over the upcoming years. This market is projected to reach $6.09 billion in 2030, exhibiting a compound annual growth rate (CAGR) of 9.3%. This expansion during the projection period stems from factors such as the increasing embrace of automated insulin delivery systems, innovations in the design of implantable medical devices, a growing need for tailored diabetes management, the spread of home-based diabetes care, and supportive reimbursement policies and regulatory frameworks. Key developments anticipated during this timeframe involve a rise in the uptake of implantable insulin delivery systems, an increasing inclination towards closed-loop insulin pumps, better glycemic management achieved through continuous insulin infusion, a greater acceptance of long-term implantable devices for diabetes, and an amplified emphasis on patient comfort and adherence to treatment regimens.
Get A Free Sample Report With In-Depth Market Insights:
Implantable Insulin Pump Market Growth Backed By Core Demand Fundamentals
The increasing occurrence of diabetes is projected to fuel the expansion of the implantable insulin pump market in the future. Diabetes, a chronic ailment, involves the body’s difficulty in regulating blood sugar, stemming from either insufficient insulin creation or cells’ impaired utilization of insulin. The growing number of diabetes instances is influenced by escalating obesity levels, insufficient exercise, poor dietary habits, and an aging demographic. An implantable insulin pump delivers insulin precisely and continuously, thereby stabilizing blood glucose, lessening the need for injections, and enhancing overall diabetes care and patient well-being. As an illustration, data from May 2024 by Diabetes UK, a UK-based charity dedicated to individuals with diabetes, revealed that more than 5.6 million people in the UK are currently managing the condition, with the 2022–23 statistics showing a rise of 167,822 cases from the previous year. Consequently, the increasing prevalence of diabetes is a key factor propelling the expansion of the implantable insulin pump market.
Implantable Insulin Pump Market Segment Breakdown: Which Categories Lead On Revenue?
The implantable insulin pump market covered in this report is segmented –
1) By Type: Fully Implantable Insulin Pump, Semi-Implantable Insulin Pump
2) By Application: Type 1 Diabetes, Type 2 Diabetes
3) By End-User: Hospitals, Diabetes Clinics, Home-Care
Subsegments:
1) By Fully Implantable Insulin Pump: Fully Automated Implantable Insulin Pump, Implantable Insulin Pump with Continuous Glucose Monitoring (CGM), Implantable Insulin Pump with Adaptive Insulin Delivery
2) By Semi-Implantable Insulin Pump: Semi-Automated Semi-Implantable Insulin Pump, Basal-Bolus Semi-Implantable Insulin Pump, Patch-Assisted Semi-Implantable Insulin Pump, Remote-Controlled Semi-Implantable Insulin Pump
Implantable Insulin Pump Market Growth Trends Reshaping The Competitive Landscape
Leading companies in the implantable insulin pump market are increasingly forming strategic partnerships to develop high-concentration, thermostable insulin formulations specifically designed for next-generation implantable pumps. For example, in May 2024, Arecor Therapeutics plc, a US-based biopharmaceutical company, collaborated with Medtronic Diabetes, a US-based medical technology company, to create a novel insulin using Arecor’s Arestat technology platform. This advanced formulation is intended for a small group of patients who have limited options with standard insulin delivery methods. The new insulin aims to enhance clinical outcomes by enabling direct hepatic absorption, reducing pump maintenance needs, expanding physician use, and potentially lowering healthcare costs. This collaboration highlights meaningful progress in diabetes care by uniting innovative drug formulation with advanced implantable delivery technology to better support patients requiring intensive insulin management.
Implantable Insulin Pump Market Competitive Landscape: Who Leads The Industry?
Major companies operating in the implantable insulin pump market are Sanofi S.A., Abbott Laboratories, Medtronic plc, Dexcom Inc., Insulet Corporation, Tandem Diabetes Care Inc., Ypsomed Holding AG, Air Liquide Healthcare Ltd., Diabeloop SA, Glooko Inc., ViCentra B.V., Bigfoot Biomedical Inc., Beta Bionics Inc., Senseonics Holdings Inc., INREDA DIABETIC B.V., TIDEPOOL Inc., Medtrum Technologies Inc., Sernova Corp., PhysioLogic Devices Inc., EOFLOW CO. LTD., CamDiab Ltd.
View The Full Implantable Insulin Pump Market Report:
Implantable Insulin Pump Market Geographic Landscape: Which Region Dominates Industry Growth?
North America was the largest region in the implantable insulin pump market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the implantable insulin pump market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Reach Out To Our Team:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
